APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pemetrexed Diacid

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pemetrexed Diacid Market Outlook and Growth Opportunities 2026

21 December 2025199 pages

Choose your research edition.

Industry ResearchPemetrexed Diacid Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Pemetrexed Diacid Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Pemetrexed Diacid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pemetrexed Diacid Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Pemetrexed Diacid Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Pemetrexed Diacid market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pemetrexed Diacid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pemetrexed Diacid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pemetrexed Diacid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pemetrexed Diacid market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pemetrexed Diacid market include Qilu Pharma, Nanjing Pharmaceutical Factory Co., Ltd., Lianyungang Tengfa Bio-tech Co., Ltd., Eli Lilly and Company, United Biotech India Pvt.Ltd., Pemgem, Onkos, Natco Pharma Ltd and Emcure, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pemetrexed Diacid market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pemetrexed Diacid and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pemetrexed Diacid sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pemetrexed Diacid market size, projected growth trends, production technologies, key applications, and end-use industries.

Pemetrexed Diacid Segment by Company

Qilu Pharma

Nanjing Pharmaceutical Factory Co., Ltd.

Lianyungang Tengfa Bio-tech Co., Ltd.

Eli Lilly and Company

United Biotech India Pvt.Ltd.

Pemgem

Onkos

Natco Pharma Ltd

Emcure

Cytotoxic

ChemOthersapy

Beacon Pharma

Actiza Parma

Pemetrexed Diacid Segment by Type

500mg Injection

300mg Injection

200mg Injection

100mg Injection

Pemetrexed Diacid Segment by Application

Mesothelioma

Non-Small Cell Lung Cancer

Others

Pemetrexed Diacid Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pemetrexed Diacid status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pemetrexed Diacid market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pemetrexed Diacid significant trends, drivers, influence factors in global and regions.

6. To analyze Pemetrexed Diacid competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pemetrexed Diacid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pemetrexed Diacid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pemetrexed Diacid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pemetrexed Diacid market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pemetrexed Diacid industry.

Chapter 3: Detailed analysis of Pemetrexed Diacid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pemetrexed Diacid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pemetrexed Diacid in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pemetrexed Diacid Industry Trends Table 2. Pemetrexed Diacid Industry Drivers Table 3. Pemetrexed Diacid Industry Opportunities and Challenges Table 4. Pemetrexed Diacid Industry Restraints Table 5. Global Pemetrexed Diacid Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pemetrexed Diacid Revenue Share by Company (2021-2026) Table 7. Global Pemetrexed Diacid Sales Volume by Company (doses) & (2021-2026) Table 8. Global Pemetrexed Diacid Sales Volume Share by Company (2021-2026) Table 9. Global Pemetrexed Diacid Average Price (US$/dose) of Company (2021-2026) Table 10. Global Pemetrexed Diacid Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pemetrexed Diacid Key Company Manufacturing Base & Headquarters Table 12. Global Pemetrexed Diacid Company, Product Type & Application Table 13. Global Pemetrexed Diacid Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pemetrexed Diacid by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 500mg Injection Table 18. Significant Companies of 300mg Injection Table 19. Significant Companies of 200mg Injection Table 20. Significant Companies of 100mg Injection Table 21. Global Pemetrexed Diacid Sales Volume by Type 2021 VS 2025 VS 2032 (doses) Table 22. Global Pemetrexed Diacid Sales Volume by Type (2021-2026) & (doses) Table 23. Global Pemetrexed Diacid Sales Volume by Type (2027-2032) & (doses) Table 24. Global Pemetrexed Diacid Sales Volume Share by Type (2021-2026) Table 25. Global Pemetrexed Diacid Sales Volume Share by Type (2027-2032) Table 26. Global Pemetrexed Diacid Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pemetrexed Diacid Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Pemetrexed Diacid Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Pemetrexed Diacid Sales Value Share by Type (2021-2026) Table 30. Global Pemetrexed Diacid Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Mesothelioma Table 32. Significant Companies of Non-Small Cell Lung Cancer Table 33. Significant Companies of Others Table 34. Global Pemetrexed Diacid Sales Volume by Application 2021 VS 2025 VS 2032 (doses) Table 35. Global Pemetrexed Diacid Sales Volume by Application (2021-2026) & (doses) Table 36. Global Pemetrexed Diacid Sales Volume by Application (2027-2032) & (doses) Table 37. Global Pemetrexed Diacid Sales Volume Share by Application (2021-2026) Table 38. Global Pemetrexed Diacid Sales Volume Share by Application (2027-2032) Table 39. Global Pemetrexed Diacid Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Pemetrexed Diacid Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Pemetrexed Diacid Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Pemetrexed Diacid Sales Value Share by Application (2021-2026) Table 43. Global Pemetrexed Diacid Sales Value Share by Application (2027-2032) Table 44. Global Pemetrexed Diacid Sales by Region: 2021 VS 2025 VS 2032 (doses) Table 45. Global Pemetrexed Diacid Sales by Region (2021-2026) & (doses) Table 46. Global Pemetrexed Diacid Sales Market Share by Region (2021-2026) Table 47. Global Pemetrexed Diacid Sales by Region (2027-2032) & (doses) Table 48. Global Pemetrexed Diacid Sales Market Share by Region (2027-2032) Table 49. Global Pemetrexed Diacid Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Pemetrexed Diacid Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Pemetrexed Diacid Sales Value Share by Region (2021-2026) Table 52. Global Pemetrexed Diacid Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Pemetrexed Diacid Sales Value Share by Region (2027-2032) Table 54. Global Pemetrexed Diacid Market Average Price (US$/dose) by Region (2021-2026) Table 55. Global Pemetrexed Diacid Market Average Price (US$/dose) by Region (2027-2032) Table 56. Global Pemetrexed Diacid Sales by Country: 2021 VS 2025 VS 2032 (doses) Table 57. Global Pemetrexed Diacid Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Pemetrexed Diacid Sales by Country (2021-2026) & (doses) Table 59. Global Pemetrexed Diacid Sales Market Share by Country (2021-2026) Table 60. Global Pemetrexed Diacid Sales by Country (2027-2032) & (doses) Table 61. Global Pemetrexed Diacid Sales Market Share by Country (2027-2032) Table 62. Global Pemetrexed Diacid Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Pemetrexed Diacid Sales Value Market Share by Country (2021-2026) Table 64. Global Pemetrexed Diacid Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Pemetrexed Diacid Sales Value Market Share by Country (2027-2032) Table 66. Qilu Pharma Company Information Table 67. Qilu Pharma Business Overview Table 68. Qilu Pharma Pemetrexed Diacid Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 69. Qilu Pharma Pemetrexed Diacid Product Portfolio Table 70. Qilu Pharma Recent Development Table 71. Nanjing Pharmaceutical Factory Co., Ltd. Company Information Table 72. Nanjing Pharmaceutical Factory Co., Ltd. Business Overview Table 73. Nanjing Pharmaceutical Factory Co., Ltd. Pemetrexed Diacid Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 74. Nanjing Pharmaceutical Factory Co., Ltd. Pemetrexed Diacid Product Portfolio Table 75. Nanjing Pharmaceutical Factory Co., Ltd. Recent Development Table 76. Lianyungang Tengfa Bio-tech Co., Ltd. Company Information Table 77. Lianyungang Tengfa Bio-tech Co., Ltd. Business Overview Table 78. Lianyungang Tengfa Bio-tech Co., Ltd. Pemetrexed Diacid Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 79. Lianyungang Tengfa Bio-tech Co., Ltd. Pemetrexed Diacid Product Portfolio Table 80. Lianyungang Tengfa Bio-tech Co., Ltd. Recent Development Table 81. Eli Lilly and Company Company Information Table 82. Eli Lilly and Company Business Overview Table 83. Eli Lilly and Company Pemetrexed Diacid Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 84. Eli Lilly and Company Pemetrexed Diacid Product Portfolio Table 85. Eli Lilly and Company Recent Development Table 86. United Biotech India Pvt.Ltd. Company Information Table 87. United Biotech India Pvt.Ltd. Business Overview Table 88. United Biotech India Pvt.Ltd. Pemetrexed Diacid Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 89. United Biotech India Pvt.Ltd. Pemetrexed Diacid Product Portfolio Table 90. United Biotech India Pvt.Ltd. Recent Development Table 91. Pemgem Company Information Table 92. Pemgem Business Overview Table 93. Pemgem Pemetrexed Diacid Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 94. Pemgem Pemetrexed Diacid Product Portfolio Table 95. Pemgem Recent Development Table 96. Onkos Company Information Table 97. Onkos Business Overview Table 98. Onkos Pemetrexed Diacid Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 99. Onkos Pemetrexed Diacid Product Portfolio Table 100. Onkos Recent Development Table 101. Natco Pharma Ltd Company Information Table 102. Natco Pharma Ltd Business Overview Table 103. Natco Pharma Ltd Pemetrexed Diacid Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 104. Natco Pharma Ltd Pemetrexed Diacid Product Portfolio Table 105. Natco Pharma Ltd Recent Development Table 106. Emcure Company Information Table 107. Emcure Business Overview Table 108. Emcure Pemetrexed Diacid Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 109. Emcure Pemetrexed Diacid Product Portfolio Table 110. Emcure Recent Development Table 111. Cytotoxic Company Information Table 112. Cytotoxic Business Overview Table 113. Cytotoxic Pemetrexed Diacid Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 114. Cytotoxic Pemetrexed Diacid Product Portfolio Table 115. Cytotoxic Recent Development Table 116. ChemOthersapy Company Information Table 117. ChemOthersapy Business Overview Table 118. ChemOthersapy Pemetrexed Diacid Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 119. ChemOthersapy Pemetrexed Diacid Product Portfolio Table 120. ChemOthersapy Recent Development Table 121. Beacon Pharma Company Information Table 122. Beacon Pharma Business Overview Table 123. Beacon Pharma Pemetrexed Diacid Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 124. Beacon Pharma Pemetrexed Diacid Product Portfolio Table 125. Beacon Pharma Recent Development Table 126. Actiza Parma Company Information Table 127. Actiza Parma Business Overview Table 128. Actiza Parma Pemetrexed Diacid Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 129. Actiza Parma Pemetrexed Diacid Product Portfolio Table 130. Actiza Parma Recent Development Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. Pemetrexed Diacid Distributors List Table 134. Pemetrexed Diacid Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Pemetrexed Diacid Product Image Figure 2. Global Pemetrexed Diacid Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pemetrexed Diacid Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pemetrexed Diacid Sales (2021-2032) & (doses) Figure 5. Global Pemetrexed Diacid Sales Average Price (US$/dose) & (2021-2032) Figure 6. Global Pemetrexed Diacid Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 500mg Injection Image Figure 10. 300mg Injection Image Figure 11. 200mg Injection Image Figure 12. 100mg Injection Image Figure 13. Global Pemetrexed Diacid Sales Volume by Type (2021 VS 2025 VS 2032) & (doses) Figure 14. Global Pemetrexed Diacid Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Pemetrexed Diacid Sales Volume Share by Type (2021-2032) Figure 16. Global Pemetrexed Diacid Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pemetrexed Diacid Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Pemetrexed Diacid Sales Value Share by Type (2021-2032) Figure 19. Mesothelioma Image Figure 20. Non-Small Cell Lung Cancer Image Figure 21. Others Image Figure 22. Global Pemetrexed Diacid Sales Volume by Application (2021 VS 2025 VS 2032) & (doses) Figure 23. Global Pemetrexed Diacid Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Pemetrexed Diacid Sales Volume Share by Application (2021-2032) Figure 25. Global Pemetrexed Diacid Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Pemetrexed Diacid Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Pemetrexed Diacid Sales Value Share by Application (2021-2032) Figure 28. Global Pemetrexed Diacid Sales by Region: 2021 VS 2025 VS 2032 (doses) Figure 29. Global Pemetrexed Diacid Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Pemetrexed Diacid Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Pemetrexed Diacid Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Pemetrexed Diacid Sales Value (2021-2032) & (US$ Million) Figure 33. North America Pemetrexed Diacid Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Pemetrexed Diacid Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Pemetrexed Diacid Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Pemetrexed Diacid Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Pemetrexed Diacid Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Pemetrexed Diacid Sales Value (2021-2032) & (US$ Million) Figure 39. South America Pemetrexed Diacid Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Pemetrexed Diacid Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Pemetrexed Diacid Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Pemetrexed Diacid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Pemetrexed Diacid Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Pemetrexed Diacid Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • 500mg Injection
  • 300mg Injection
  • 200mg Injection
  • 100mg Injection
Applications
  • Mesothelioma
  • Non-Small Cell Lung Cancer
  • Others
Companies covered
  • Qilu Pharma
  • Nanjing Pharmaceutical Factory Co., Ltd.
  • Lianyungang Tengfa Bio-tech Co., Ltd.
  • Eli Lilly and Company
  • United Biotech India Pvt.Ltd.
  • Pemgem
  • Onkos
  • Natco Pharma Ltd
  • Emcure
  • Cytotoxic
  • ChemOthersapy
  • Beacon Pharma
  • Actiza Parma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pemetrexed Diacid Sales Value (2021-2032)
  4. 1.2.2 Global Pemetrexed Diacid Sales Volume (2021-2032)
  5. 1.2.3 Global Pemetrexed Diacid Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pemetrexed Diacid Market Dynamics
  1. 2.1 Pemetrexed Diacid Industry Trends
  2. 2.2 Pemetrexed Diacid Industry Drivers
  3. 2.3 Pemetrexed Diacid Industry Opportunities and Challenges
  4. 2.4 Pemetrexed Diacid Industry Restraints
3 Pemetrexed Diacid Market by Company
  1. 3.1 Global Pemetrexed Diacid Company Revenue Ranking in 2025
  2. 3.2 Global Pemetrexed Diacid Revenue by Company (2021-2026)
  3. 3.3 Global Pemetrexed Diacid Sales Volume by Company (2021-2026)
  4. 3.4 Global Pemetrexed Diacid Average Price by Company (2021-2026)
  5. 3.5 Global Pemetrexed Diacid Company Ranking (2024-2026)
  6. 3.6 Global Pemetrexed Diacid Company Manufacturing Base and Headquarters
  7. 3.7 Global Pemetrexed Diacid Company Product Type and Application
  8. 3.8 Global Pemetrexed Diacid Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pemetrexed Diacid Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pemetrexed Diacid Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pemetrexed Diacid Market by Type
  1. 4.1 Pemetrexed Diacid Type Introduction
  2. 4.1.1 500mg Injection
  3. 4.1.2 300mg Injection
  4. 4.1.3 200mg Injection
  5. 4.1.4 100mg Injection
  6. 4.2 Global Pemetrexed Diacid Sales Volume by Type
  7. 4.2.1 Global Pemetrexed Diacid Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pemetrexed Diacid Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Pemetrexed Diacid Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Pemetrexed Diacid Sales Value by Type
  11. 4.3.1 Global Pemetrexed Diacid Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Pemetrexed Diacid Sales Value by Type (2021-2032)
  13. 4.3.3 Global Pemetrexed Diacid Sales Value Share by Type (2021-2032)
5 Pemetrexed Diacid Market by Application
  1. 5.1 Pemetrexed Diacid Application Introduction
  2. 5.1.1 Mesothelioma
  3. 5.1.2 Non-Small Cell Lung Cancer
  4. 5.1.3 Others
  5. 5.2 Global Pemetrexed Diacid Sales Volume by Application
  6. 5.2.1 Global Pemetrexed Diacid Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pemetrexed Diacid Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Pemetrexed Diacid Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Pemetrexed Diacid Sales Value by Application
  10. 5.3.1 Global Pemetrexed Diacid Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pemetrexed Diacid Sales Value by Application (2021-2032)
  12. 5.3.3 Global Pemetrexed Diacid Sales Value Share by Application (2021-2032)
6 Pemetrexed Diacid Regional Sales and Value Analysis
  1. 6.1 Global Pemetrexed Diacid Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pemetrexed Diacid Sales by Region (2021-2032)
  3. 6.2.1 Global Pemetrexed Diacid Sales by Region: 2021-2026
  4. 6.2.2 Global Pemetrexed Diacid Sales by Region (2027-2032)
  5. 6.3 Global Pemetrexed Diacid Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pemetrexed Diacid Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pemetrexed Diacid Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pemetrexed Diacid Sales Value by Region (2027-2032)
  9. 6.5 Global Pemetrexed Diacid Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pemetrexed Diacid Sales Value (2021-2032)
  12. 6.6.2 North America Pemetrexed Diacid Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pemetrexed Diacid Sales Value (2021-2032)
  15. 6.7.2 Europe Pemetrexed Diacid Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pemetrexed Diacid Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pemetrexed Diacid Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pemetrexed Diacid Sales Value (2021-2032)
  21. 6.9.2 South America Pemetrexed Diacid Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pemetrexed Diacid Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pemetrexed Diacid Sales Value Share by Country, 2025 VS 2032
7 Pemetrexed Diacid Country-level Sales and Value Analysis
  1. 7.1 Global Pemetrexed Diacid Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pemetrexed Diacid Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pemetrexed Diacid Sales by Country (2021-2032)
  4. 7.3.1 Global Pemetrexed Diacid Sales by Country (2021-2026)
  5. 7.3.2 Global Pemetrexed Diacid Sales by Country (2027-2032)
  6. 7.4 Global Pemetrexed Diacid Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pemetrexed Diacid Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pemetrexed Diacid Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pemetrexed Diacid Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pemetrexed Diacid Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pemetrexed Diacid Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Qilu Pharma
  2. 8.1.1 Qilu Pharma Company Information
  3. 8.1.2 Qilu Pharma Business Overview
  4. 8.1.3 Qilu Pharma Pemetrexed Diacid Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Qilu Pharma Pemetrexed Diacid Product Portfolio
  6. 8.1.5 Qilu Pharma Recent Developments
  7. 8.2 Nanjing Pharmaceutical Factory Co., Ltd.
  8. 8.2.1 Nanjing Pharmaceutical Factory Co., Ltd. Company Information
  9. 8.2.2 Nanjing Pharmaceutical Factory Co., Ltd. Business Overview
  10. 8.2.3 Nanjing Pharmaceutical Factory Co., Ltd. Pemetrexed Diacid Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Nanjing Pharmaceutical Factory Co., Ltd. Pemetrexed Diacid Product Portfolio
  12. 8.2.5 Nanjing Pharmaceutical Factory Co., Ltd. Recent Developments
  13. 8.3 Lianyungang Tengfa Bio-tech Co., Ltd.
  14. 8.3.1 Lianyungang Tengfa Bio-tech Co., Ltd. Company Information
  15. 8.3.2 Lianyungang Tengfa Bio-tech Co., Ltd. Business Overview
  16. 8.3.3 Lianyungang Tengfa Bio-tech Co., Ltd. Pemetrexed Diacid Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Lianyungang Tengfa Bio-tech Co., Ltd. Pemetrexed Diacid Product Portfolio
  18. 8.3.5 Lianyungang Tengfa Bio-tech Co., Ltd. Recent Developments
  19. 8.4 Eli Lilly and Company
  20. 8.4.1 Eli Lilly and Company Company Information
  21. 8.4.2 Eli Lilly and Company Business Overview
  22. 8.4.3 Eli Lilly and Company Pemetrexed Diacid Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Eli Lilly and Company Pemetrexed Diacid Product Portfolio
  24. 8.4.5 Eli Lilly and Company Recent Developments
  25. 8.5 United Biotech India Pvt.Ltd.
  26. 8.5.1 United Biotech India Pvt.Ltd. Company Information
  27. 8.5.2 United Biotech India Pvt.Ltd. Business Overview
  28. 8.5.3 United Biotech India Pvt.Ltd. Pemetrexed Diacid Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 United Biotech India Pvt.Ltd. Pemetrexed Diacid Product Portfolio
  30. 8.5.5 United Biotech India Pvt.Ltd. Recent Developments
  31. 8.6 Pemgem
  32. 8.6.1 Pemgem Company Information
  33. 8.6.2 Pemgem Business Overview
  34. 8.6.3 Pemgem Pemetrexed Diacid Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Pemgem Pemetrexed Diacid Product Portfolio
  36. 8.6.5 Pemgem Recent Developments
  37. 8.7 Onkos
  38. 8.7.1 Onkos Company Information
  39. 8.7.2 Onkos Business Overview
  40. 8.7.3 Onkos Pemetrexed Diacid Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Onkos Pemetrexed Diacid Product Portfolio
  42. 8.7.5 Onkos Recent Developments
  43. 8.8 Natco Pharma Ltd
  44. 8.8.1 Natco Pharma Ltd Company Information
  45. 8.8.2 Natco Pharma Ltd Business Overview
  46. 8.8.3 Natco Pharma Ltd Pemetrexed Diacid Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Natco Pharma Ltd Pemetrexed Diacid Product Portfolio
  48. 8.8.5 Natco Pharma Ltd Recent Developments
  49. 8.9 Emcure
  50. 8.9.1 Emcure Company Information
  51. 8.9.2 Emcure Business Overview
  52. 8.9.3 Emcure Pemetrexed Diacid Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Emcure Pemetrexed Diacid Product Portfolio
  54. 8.9.5 Emcure Recent Developments
  55. 8.10 Cytotoxic
  56. 8.10.1 Cytotoxic Company Information
  57. 8.10.2 Cytotoxic Business Overview
  58. 8.10.3 Cytotoxic Pemetrexed Diacid Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Cytotoxic Pemetrexed Diacid Product Portfolio
  60. 8.10.5 Cytotoxic Recent Developments
  61. 8.11 ChemOthersapy
  62. 8.11.1 ChemOthersapy Company Information
  63. 8.11.2 ChemOthersapy Business Overview
  64. 8.11.3 ChemOthersapy Pemetrexed Diacid Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 ChemOthersapy Pemetrexed Diacid Product Portfolio
  66. 8.11.5 ChemOthersapy Recent Developments
  67. 8.12 Beacon Pharma
  68. 8.12.1 Beacon Pharma Company Information
  69. 8.12.2 Beacon Pharma Business Overview
  70. 8.12.3 Beacon Pharma Pemetrexed Diacid Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Beacon Pharma Pemetrexed Diacid Product Portfolio
  72. 8.12.5 Beacon Pharma Recent Developments
  73. 8.13 Actiza Parma
  74. 8.13.1 Actiza Parma Company Information
  75. 8.13.2 Actiza Parma Business Overview
  76. 8.13.3 Actiza Parma Pemetrexed Diacid Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Actiza Parma Pemetrexed Diacid Product Portfolio
  78. 8.13.5 Actiza Parma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pemetrexed Diacid Value Chain Analysis
  2. 9.1.1 Pemetrexed Diacid Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pemetrexed Diacid Sales Mode & Process
  6. 9.2 Pemetrexed Diacid Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pemetrexed Diacid Distributors
  9. 9.2.3 Pemetrexed Diacid Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst